Maintenance chemotherapy for advanced Hodgkin's disease in remission.
D001772:Blood Cell Count; D001792:Blood Platelets; D006689:Hodgkin Disease / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D008214:Lymphocytes; D008466:Mechlorethamine / Q000008:administration & dosage / Q000627:therapeutic use; D009607:Nitrosourea Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D055728:Primary Myelofibrosis / Q000150:complications; D011344:Procarbazine / Q000008:administration & dosage / Q000627:therapeutic use; D011379:Prognosis; D012008:Recurrence; D012075:Remission, Spontaneous; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage / Q000627:therapeutic use
D009607:Nitrosourea Compounds; D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone